Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
about
Treatment of allergic asthma: modulation of Th2 cells and their responses(Quasi-)racemic X-ray structures of glycosylated and non-glycosylated forms of the chemokine Ser-CCL1 prepared by total chemical synthesisMouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cellsC-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activityRequirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cellsEngagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.New drugs targeting Th2 lymphocytes in asthma.Multiple roles for chemokines in the pathogenesis of SIV infectionFunctional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infectionTh2 cells as targets for therapeutic intervention in allergic bronchial asthma.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Targeting chemokine receptors in allergic disease.Internalization: what does it tell us about pharmacokinetic and pharmacodynamic properties of an antagonist?Total chemical synthesis and biological activities of glycosylated and non-glycosylated forms of the chemokines CCL1 and Ser-CCL1.Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.(Quasi-)Racemic X-ray Structures of Glycosylated and Non-Glycosylated Forms of the Chemokine Ser-CCL1 Prepared by Total Chemical Synthesis
P2860
Q27011823-4E3E02F4-5D0B-445B-B334-F6D96763D039Q27689681-7C43F287-5F4F-4692-871D-A04468870F99Q28302789-276685C9-F104-42D3-879B-D5BDB6BA438DQ28730907-FAB95656-DE06-4D63-8903-240708222AECQ30494984-C72B9E6D-A6CA-4E06-AE1F-1406E47159E9Q35067528-715740BC-01FA-4E10-98AF-9FBC541A19CDQ36419287-7E55B5A9-6AF4-48EE-BC08-367DAEA6450EQ36485165-8817080C-E884-4EEE-9D49-A7E674888930Q36634172-50BD7B2A-4246-433B-8A8F-BBD890248BF7Q36677825-A155FFD9-503B-480F-BE07-2D499136CC3FQ36938152-8D11CBB6-2953-4931-A30E-14E369213CCFQ37355888-DD455009-BF25-465D-87BD-3D4D910B2364Q37432097-783BFFF2-A53E-432E-829B-C5F9D0F80053Q37832529-35A8C04D-6D8B-4C13-BDEA-D822AD8E404FQ42940459-66AD9630-76F3-4DAE-8B69-C232F94495B1Q46111348-6FEE409F-3413-49D8-9264-76E205DDC90EQ55497820-DA7573B9-7A46-47E4-B7C8-AB1062EDCD6CQ57909608-4EB71CEF-DCEB-4329-B624-61B783A019A7
P2860
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Structure/function relationshi ...... d generates a partial agonist.
@en
type
label
Structure/function relationshi ...... d generates a partial agonist.
@en
prefLabel
Structure/function relationshi ...... d generates a partial agonist.
@en
P2093
P2860
P50
P356
P1476
Structure/function relationshi ...... id generates a partial agonist
@en
P2093
Geoffrey L Smith
James E Pease
Pilar Najarro
P2860
P304
36652-36661
P356
10.1074/JBC.M605584200
P407
P577
2006-10-05T00:00:00Z